Back to top

Biohaven reports Q2 EPS (78c), consensus (61c)

Cash, cash equivalents, marketable securities and restricted cash as of June 30, 2026, totaled approximately $270.5M. Vlad Coric, M.D., Chairman an...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Biohaven Ltd. (BHVN)